Skip to main content

Table 3 Indications for controls

From: Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature

Controls over time:
No agreed indication
Monitoring TSH and fT4 at least every 3 months in patients on one phosphate binder + one other potentially interfering drug (on the basis of the high levels found in the previous studies, and in ours)
Monthly monitoring if unstable TSH or if new potentially interfering drugs, change in dose of phosphate binder, or more than 2 potentially interfering drugs (importance of early diagnosis)
Reduce frequency when there has been long-term stability, and no change in treatment (probably wise to monitor patient at least twice a year)